New Drug Delivery System Targets Diseases at a Genetic Level

News   Dec 06, 2017 | Original story from University of Connecticut

 
New Drug Delivery System Targets Diseases at a Genetic Level

Enzyme-triggered degradation of a drug loaded peptide-crosslinked nucleic acid nanocapsule. First a peptide is crosslinked at the nanoparticle surface (1), then an enzyme recognizes the peptide crosslinker (2), and finally the enzyme cleavage leads to the release of the drug and any intact DNA (3). Credit: (Artwork by Joseph Luciani/UConn)

 
 
 

RELATED ARTICLES

Chemical Imaging Reveals Details of Ancient Artwork

News

Scientists have used a combination of three advanced imaging techniques to produce a highly detailed analysis of a second century Egyptian painting. They are the first to use the specific combination — which they termed “macroscale multimodal chemical imaging” — to examine an ancient work of art.

READ MORE

Hyperlens Crystal Capable of Viewing Living Cells in Unprecedented Detail

News

Just imagine: An optical lens so powerful that it lets you view features the size of a small virus on the surface of a living cell in its natural environment. Fundamental advances in the quality of an optical material used in hyperlensing, a method of creating lenses that can resolve objects much smaller than the wavelength of light, now makes this possible.

READ MORE

Some Immune Cells May Help Tumors Instead of Destroying Them

News

New data shows that neutrophils promote tumor progression and can actually hamper the work of immunotherapy in lung cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE